TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

TherapeuticsMD, Inc.

6800 Broken Sound Parkway NW
Third Floor
Boca Raton, FL 33487
United States
561-961-1900
http://www.therapeuticsmd.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees241

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert G. FinizioCo-Founder, CEO & Director1.37M7.5M1971
Mr. John C. K. Milligan IVPres, Sec. & Director869.21k10.54M1962
Mr. Daniel Alan CartwrightCFO & Treasurer721.48k346.4k1958
Mr. Mitchell L. KrassanExec. VP and Chief Strategy & Performance Officer605.36kN/A1966
Mr. Michael DoneganVP of Fin.395.25kN/A1968
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

TherapeuticsMD, Inc. operates as a women's health care product company in the United States. The company's hormone therapy drug candidate is the TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil. Its preclinical projects include the development of TX-005HR, a topical progesterone cream; TX-006HR, an estradiol and progesterone topical cream to penetrate human skin; and TX-00THR and TX-0008HR, which are transdermal patch forms. The company also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. In addition, it commercializes IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Corporate Governance

TherapeuticsMD, Inc.’s ISS Governance QualityScore as of June 25, 2019 is 4. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 2; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.